Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study

Published:2018-04-02 Issue:3 Volume:181 Page:341-349
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Deau Benedicte¹^ORCID,Amorim Sandy²,Perrot Aurore³,Quittet Philippe⁴,Cornillon Jerome⁵,Chaoui Driss⁶,Marolleau Jean P.⁷,Oberic Lucie⁸,Le Du Katell⁹,Fornecker Luc-Matthieu¹⁰,Tournilhac Olivier¹¹^ORCID,Veillard Anne S.¹²,Chaillol Isabelle¹²,Robin Marie²,Tamburini Jérôme¹,Brice Pauline²

Affiliation:

1. Hopital Cochin; Paris France

2. Hopital Saint Louis; Paris France

3. CHU Nancy; Vandroeuvre France

4. CHU Montpellier; Montpellier France

5. Institut Cancerologique de la Loire; St-Priest en Jarez France

6. CH Argenteuil; Argenteuil France

7. CH Amiens; Amiens France

8. CHU Toulouse; Toulouse France

9. Clinique Victor Hugo Le Mans; Le Mans France

10. CHU Strasbourg; Strasbourg France

11. CHU Clermont Ferrand; Clermont-Ferrand France

12. Lymphoma Academic Research Organisation (LYSARC); Lyon France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15184/fullpdf

Reference29 articles.

1. Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle;André;Journal of Clinical Oncolog,1999

2. Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial;Blaise;Haematologica,2015

3. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients;Brice;Cancer,1996

4. Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD) SFGM/GELA Study Group;Brice;Annals of Oncology,1999

5. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma;Bröckelmann;Annals of Oncology: Official Journal of the European Society for Medical Oncology,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA;British Journal of Haematology;2023-05-16

2. Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience;Journal of Modern Oncology;2022-11-25

3. Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study;Leukemia & Lymphoma;2022-08-17

4. Classical Hodgkin lymphoma;The Lancet;2021-10

5. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis;Haematologica;2021-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3